Skip to Content

Research & Funding

Past CIP InitiativesRSS

This page lists past opportunities from CIP.

Requests for Application (RFA) are usually announced with special application dates; there is no possibility for applying after that date. Program Announcements (PA, PAR) may be open for a set period of time, such as 3 years or less; applications submitted in response to Program Announcements may be due on the standard dates (February 1, June1, and October 1) or may have special dates for receipt of applications. Please pay attention to these dates. Contact a CIP staff member if you have questions.

  • NCI RFA: CA-05-006: Innovative Technologies for Molecular Analysis of Cancer (SBIR/STTR)

    • Release Date: January 07, 2004
    • Application Receipt Date: March 10, 2004; June 17, 2004; October 18, 2004
    • Contacts:

      Barbara Y. Croft, Ph.D. (bc129b@nih.gov) at 301-496-9531

    The NCI invites applications for research projects proposing the development of highly innovative cancer relevant technologies, encompassing methods and tools that enable research, including, but not limited to, instrumentation, techniques, and devices. Technology is distinct from resources such as databases, reagents, and tissue repositories.

    • Letter of Intent Receipt Date(s): February 10, 2004; May 17, 2004; September 17, 2004

    See full description in NIH Guide:RFA: CA-05-006

  • PA-04-045: In Vivo Cancer Imaging Exploratory/Developmental Grants (R21)

    • Release Date: December 24, 2003
    • Application Receipt Date: February 1, June 1, and October 1
    • Contacts:

      Anne E. Menkens, Ph.D. (am187k@nih.gov) at 301-435-9024

    The Cancer Imaging Program (CIP) of the Division of Cancer Treatment and Diagnosis (DCTD) solicits exploratory/developmental (R21) applications that articulate exploratory/developmental research focused on in vivo cancer imaging. The R21 mechanism will provide investigators at all career levels with a defined level of funding adequate for the initial development and/or feasibility testing of high impact concepts. Topics considered responsive to this Program Announcement will cover the entire spectrum of in vivo cancer imaging research, from basic discovery of new cancer imaging agents and technologies, through pre-clinical testing and validation, to the early feasibility testing of those novel agents and technologies in small clinical trials. The applicant may request a project period of up to two years with a combined budget for direct costs of up $275,000 for the two year period.

    • No set-aside

    See full description in NIH Guide:PA-04-045

  • PA-04-046: Clinical Cancer Therapy and Prevention Research

    • Release Date: December 24, 2003
    • Application Receipt Date: February 1, June 1, and October 1
    • Contacts:

      Keyvan Farahani, Ph.D. (farahank@mail.nih.gov) at 301-451-2651

    The NCI is seeking R01 applications to conduct translational, clinical, therapeutic, and preventive studies/trials of neoplastic diseases in humans and encourages clinical researchers to collaborate with basic scientists to translate insights in cancer biology and the development of new anti-cancer agents into innovative cancer intervention studies/trials. The overall aims of this renewed PA are two-fold: (1) to stimulate development of innovative therapeutic/preventive clinical trials with or without laboratory correlative studies (2) to support innovative correlative laboratory studies linked to therapeutic/preventive clinical trials. Investigators may address either aim in their applications.

    • No set-aside

    See full description in NIH Guide:PA-04-046

  • NCI/NIH RFA: CA-04-011: Small Animal Imaging Resource Programs

    • Release Date: October 02, 2003
    • Application Receipt Date: December 18, 2003
    • Contacts:

      Barbara Y. Croft, Ph.D. (bc129b@nih.gov) at 301-496-9531

    The National Cancer Institute (NCI) invites applications from extramural investigators for Small Animal Imaging Resource Programs (SAIRPs). These grants will support (a) shared imaging research resources to be used by cancer investigators, (b) research related to small animal imaging technology, and (c) training of both professional and technical support personnel interested in the science and techniques of small animal imaging.

    • Letter of Intent Receipt Date(s): November 18, 2003

    See full description in NIH Guide:NCI/NIH RFA: CA-04-011

  • PAR-03-157: Industry-Academic Partnerships for Development of Biomedical Imaging Systems and Methods that are Cancer Specific (R21)

    • Release Date: July 29, 2003
    • Application Receipt Date: November 19, 2003; November 17, 2004
    • Contacts:

      Guoying Liu, Ph.D. (liug@mail.nih.gov) at 301-594-5220

    The National Cancer Institute (NCI) invites applications for the pursuit of industry-academic partnerships for development of biomedical imaging systems and methods that are cancer specific. Support for the exchange of scientists between industry and academia can be requested under this initiative.

    The goals of this initiative are to

    1) Provide grants to help establish and/or expand industry-academic partnerships for development of biomedical imaging systems and methods that are cancer specific whether or not preliminary data or a history of prior collaborations have been established;

    2) Support partnerships and pilot projects that may result in commercialization of imaging technologies;

    3) Target partnerships that address high-risk/high-gain research and development of new approaches for early cancer detection, diagnosis, image-guided interventions, and assessment of drug therapy.

    • Letter of Intent Receipt Date(s): October 22, 2003; October 20, 2004

    See full description in NIH Guide: PAR-03-157

    What is the R21 grant mechanism?

  • PAR-03-124: Novel Technologies for In vivo Imaging (R21/R33)

    • Release Date: May 19, 2003
    • Application Receipt Date: July 21, 2003 and November 19, 2003
    • Contacts:

      Houston Baker, Ph.D. (bakerhou@mail.nih.gov)

    PAR-03-124 has been replaced by PA-04-095, which uses Regular Receipt Dates: June 1, October 1, and February 1.

    The National Cancer Institute (NCI) and the National Institute for Biomedical Imaging and Bioengineering (NIBIB) invite applications for the development and delivery of novel image acquisition or enhancement technology and methods for biomedical imaging and image-guided interventions and therapy, and which may incorporate limited pilot or clinical feasibility evaluations using either pre-clinical models or clinical studies. This initiative is intended to facilitate the proof of feasibility, development and delivery of novel imaging technologies for early detection, screening, diagnosis, image-guided interventions, and treatment of various diseases, and secondarily to facilitate limited evaluation studies to show proof of concept and functionality.

    • Letter of Intent Receipt Date(s): June 23, 2003 and October 22, 2003

    See full description in NIH Guide:PAR-03-124

    See full description in NIH Guide:PA-04-095

  • PAR-03-125: Novel Technologies for In vivo Imaging (SBIR/STTR)

    • Release Date: May 19, 2003
    • Application Receipt Date: July 21, 2003 and November 19, 2003
    • Contacts:

      Houston Baker, Ph.D. (bakerhou@mail.nih.gov)

    PAR-03-125 has been replaced by PA-04-094, which uses Regular Receipt Dates: August 1, December 1, and April 1.

    The National Cancer Institute (NCI), the National Institute of Environmental Health Sciences (NIEHS), the National Institute for Biomedical Imaging and Bioengineering (NIBIB) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invite applications for the development and delivery of novel image acquisition or enhancement technology and methods for biomedical imaging and image-guided interventions and therapy, and which may incorporate limited pilot or clinical feasibility evaluations using either pre-clinical models or clinical studies. This initiative is intended to facilitate the proof of feasibility, development and delivery of novel imaging technologies for early detection, screening, diagnosis, image-guided interventions and treatment of various diseases, and secondarily to facilitate limited evaluation studies to show proof of concept and functionality.

    • Letter of Intent Receipt Date(s): June 23, 2003 and October 22, 2003

    See full description in NIH Guide:PAR-03-125

    See full description in NIH Guide:PA-04-094

  • NOT-CA-03-026: Instrumentation Grants for Imaging Equipment Used in Clinical Trials: Administrative Supplements to Cancer Center Support Grants (P30)

    • Release Date: April 11, 2003
    • Application Receipt Date: June 20, 2003
    • Contacts:

      Guoying Liu, Ph.D. (liug@mail.nih.gov)

    The National Cancer Institute (NCI) is announcing the availability of administrative supplemental funds for NCI-funded cancer center grantees (P30s) (domestic only). The primary purpose of this initiative is to provide matching funds to assist in the acquisition of dedicated clinical research imaging equipment, or significant upgrades to existing clinical research imaging equipment (software and/or hardware), in order to optimize the use of imaging as a biomarker in Phase 1 and 2 oncologic trials. The initiative is part of a continuing effort to stimulate and strengthen the use of imaging techniques in cancer research. NCI-funded cancer centers possess the infrastructure, organization, leadership, and integrated multidisciplinary research objectives that enable them to build and incorporate new image technologies into cancer clinical trials.

    See full description in NIH Guide:NOT-CA 03-026

  • NOT-CA-03-016: Administrative Supplement Requests: Instrumentation Grants for Small Animal Imaging Equipment

    • Release Date: April 11, 2003
    • Application Receipt Date: June 20, 2003
    • Contacts:

      Barbara Y. Croft, Ph.D. (bc129b@nih.gov) at 301-496-9531

    The National Cancer Institute (NCI) is announcing the availability of administrative supplemental funds for NCI-funded R24, P30, P50, U01, and U54 grantees (domestic only). This administrative supplemental initiative is intended to assist the grantees in creating or extending capabilities in small animal imaging. The initiative is part of a continuing effort to stimulate and strengthen research in small animal imaging techniques and to increase the use of small animal imaging techniques in cancer research. The Instrumentation Grants For Small Animal Imaging Equipment (Administrative Supplements) will provide dedicated funds to buy or upgrade imaging equipment for small animals, emphasizing those modalities that can provide biochemical, molecular, genetic or pharmacological information in vivo.

    See full description in NIH Guide:NOT-CA 03-016

  • NCI NOT-CA-03-001: Notice of Limited Competition Request for Competitive Request for Competitive Renewal Applications: ACRIN-Biomedical Imaging (U01)

    • Release Date: December 19, 2002
    • Contacts:

      Barbara A. Galen, M.S.N., C.R.N.P. (bgalen@mail.nih.gov)

    The NCI is requesting competing renewal applications from the American College of Radiology Imaging Network (ACRIN), funded originally through RFA CA-97-020. This will continue a unique ongoing project at its current level and scope to best serve the oncology and imaging science communities. This is particularly important now because ACRIN is currently conducting several ongoing imaging clinical trials critical to the goals of the NCI. The combination of imaging with minimally invasive diagnosis and treatment will enhance clinical practice by limiting disfigurement, trauma and expense.

    See full description in NIH Guide:NCI NOT-CA-03-001